Adaptimmune Immunotherapy Increases Time It Takes for Myeloma to Progress, Trial Shows
An Adaptimmune therapy that strengthens immune T-cells’ response to cancer…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Weighing Myeloma Cells Could Predict Treatment Responses, MIT Study Shows
Weighing individual cancer cells could help doctors predict how…
First Myeloma CAR T-cell Therapy Phase 2 Trial Opens Enrollment
The U.S. Food and Drug Administration (FDA) has granted…
FDA Allows Trials of Opdivo Combo Therapy to Resume, Signaling No New Safety Concerns
The U.S. Food and Drug Administration (FDA) agreed to…
Ascentage Gets FDA Nod to Advance APG-1387 into Clinical Trials for Myeloma, Other Cancers
The U.S. Food and Drug Administration (FDA) has…
CAR T-cells Targeting Integrin β7 Protein Show Promise in Countering Multiple Myeloma Cells
A Japanese study has found that an active structure…
